This article is cross-posted from Breat Cancer Action.
Monday marked the 10th anniversary of the release of the groundbreaking results of the Women’s Health Initiative (WHI). The WHI was pioneering in the scope and scale of independent research focused on women’s health; at the time it was the largest preventive women’s health study ever conducted in the United States, and, importantly, was independently funded – by the National Institutes of Health, not pharmaceutical companies.
At Breast Cancer Action we’ve long challenged the deep and pervasive influence the pharmaceutical industry has in the research, development, and marketing of drugs in this country. The WHI study serves as a cautionary tale of what can happen when pharma pushes drugs to women without adequate safety information about those drugs.